ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine
Loading...
Files
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
S. Karger AG
Abstract
Coronavirus disease (COVID-19) vaccine can alter the body's immunological balance leading to autoimmune disease in rare cases. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is one of the autoimmune diseases which have been rarely reported to appear post-COVID-19 vaccine. Herein, we report the case of a 47-year-old woman who developed acute renal failure few days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Corticosteroids along with azathioprine were used for the management. © 2022 Authors
Description
Keywords
Acute renal failure, Anca-associated vasculitis, Autoimmunity, Coronavirus disease, Anti-neutrophil cytoplasmic antibody-associated vasculitis, Azathioprine, Bnt162 vaccine, Covid-19, Covid-19 vaccines, Female, Humans, Middle aged, Bicarbonate, C reactive protein, Creatinine, Immunoglobulin g, Methylprednisolone, Myeloperoxidase, Neutrophil cytoplasmic antibody, Prednisone, Tozinameran, Urea, Acute kidney failure, Adult, Anca associated vasculitis, Article, Atrophy, Bicarbonate blood level, Blood cell count, Case report, Clinical article, Coronavirus disease 2019, Creatinine blood level, Erythrocyte, Estimated glomerular filtration rate, Fibrosing alveolitis, Flank pain, Follow up, Functional status, Glomerulus, Glomerulus basement membrane, Human, Human cell, Human tissue, Inflammatory cell, Kidney biopsy, Kidney interstitium, Kidney tubule, Leukocyte, Leukocyte count, Leukocytosis, Limb swelling, Lower limb, Neutrophil, Periodic acid schiff stain, Peripheral edema, Physical examination, Primary medical care, Protein creatinine ratio, Protein urine level, Treatment duration, Treatment outcome, Urea blood level, Urinalysis, Vaccination, Weakness, Wrinkle, Adverse event, Prevention and control